Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis
- 6 February 2001
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 37 (2) , 569-578
- https://doi.org/10.1016/s0735-1097(00)01135-9
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart ValvesChest, 1998
- Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: A randomized trial in patients with mechanical prosthetic heart valvesThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: A metaanalysisAmerican Heart Journal, 1995
- Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.Circulation, 1994
- A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve ReplacementNew England Journal of Medicine, 1993
- Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart ValvesChest, 1992
- Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valvesJournal of the American College of Cardiology, 1986
- Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamoleThe American Journal of Cardiology, 1983
- Prevention of arterial thromboembolism with acetylsalicylic acidAmerican Heart Journal, 1977
- Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve ReplacementNew England Journal of Medicine, 1971